Seven Eight Capital, LP Gilead Sciences, Inc. Transaction History

Seven Eight Capital, LP

$1.05 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$63.15 - $72.88 $482,781 - $557,167	7,645 New	7,645 $524,000
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $725,135 - $827,118	9,540 New	9,540 $735,000
Q3 2022 Nov 10, 2022	SELL	$59.54 - $68.01 $147,480 - $168,460	-2,477 Reduced 25.96%	7,063 $436,000
Q2 2022 Aug 04, 2022	SELL	$57.72 - $65.01 $552,322 - $622,080	-9,569 Reduced 50.08%	9,540 $590,000
Q1 2022 May 11, 2022	BUY	$57.92 - $72.58 $669,265 - $838,661	11,555 Added 152.97%	19,109 $1.14 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $490,103 - $556,276	7,554 New	7,554 $548,000
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $1.64 Million - $1.8 Million	-25,900 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$56.65 - $64.55 $436,205 - $497,035	7,700 Added 42.31%	25,900 $1.51 Million
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $1.13 Million - $1.42 Million	18,200 New	18,200 $1.15 Million
Q2 2020 Aug 06, 2020	SELL	$72.34 - $84.0 $3.13 Million - $3.64 Million	-43,300 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $13.5 Million - $17.3 Million	-216,172 Reduced 83.31%	43,300 $3.24 Million
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $4.95 Million - $5.44 Million	80,289 Added 44.81%	259,472 $16.9 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $5.73 Million - $6.33 Million	91,700 Added 104.82%	179,183 $11.4 Million
Q2 2019 Aug 12, 2019	SELL	$61.87 - $69.38 $12.7 Million - $14.2 Million	-205,100 Reduced 70.1%	87,483 $5.91 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $2.49 Million - $2.79 Million	39,800 Added 15.74%	292,583 $19 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $13.8 Million - $18 Million	227,300 Added 891.97%	252,783 $15.8 Million
Q3 2018 Oct 18, 2018	BUY	$71.28 - $78.92 $1.82 Million - $2.01 Million	25,483 New	25,483 $1.97 Million
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $7.63 Million - $9.3 Million	-104,683 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$71.15 - $83.52 $7.45 Million - $8.74 Million	104,683	104,683 $7.5 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.

Account